Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 605

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis

Open access
Marti, Christophe, John, Gregor, Konstantinides, Stavros, Combescure, Christophe, Sanchez, Olivier, Lankeit, Mareike, Meyer, Guy, Perrier, Arnaud·2015·European Heart Journal

Abstract

AIM: Thrombolytic therapy induces faster clot dissolution than anticoagulation in patients with acute pulmonary embolism (PE) but is associated with an increased risk of haemorrhage. We reviewed the risks and benefits of thrombolytic therapy in the management of patients with acute PE. METHODS AND RESULTS: We systematically reviewed randomized controlled studies comparing systemic thrombolytic therapy plus anticoagulation with anticoagulation alone in patients with acute PE. Fifteen trials involving 2057 patients were included in our meta-analysis. Compared with heparin, thrombolytic therapy was associated with a significant reduction of overall mortality (OR; 0.59, 95% CI: 0.36-0.96). This reduction was not statistically significant after exclusion of studies including high-risk PE (OR; 0.64, 95% CI: 0.35-1.17). Thrombolytic therapy was associated with a significant reduction in the combined endpoint of death or treatment escalation (OR: 0.34, 95% CI: 0.22-0.53), PE-related mortality (OR: 0.29; 95% CI: 0.14-0.60) and PE recurrence (OR: 0.50; 95% CI: 0.27-0.94). Major haemorrhage (OR; 2.91, 95% CI: 1.95-4.36) and fatal or intracranial bleeding (OR: 3.18, 95% CI: 1.25-8.11) were significantly more frequent among patients receiving thrombolysis. CONCLUSIONS: Thrombolytic therapy reduces total mortality, PE recurrence, and PE-related mortality in patients with acute PE. The decrease in overall mortality is, however, not significant in haemodynamically stable patients with acute PE. Thrombolytic therapy is associated with an increase of major and fatal or intracranial haemorrhage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehu218

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 3

  1. Kroger, 2010, Incidence rate of pulmonary embolism in Germany: data from the federal statistical office, J Thromb Thrombolysis, 29, 349, 10.1007/s11239-009-0396-1 · doi:10.1007/s11239-009-0396-1
  2. Kline, 2013, Randomized trial of tenecteplase or placebo with low-molecular weight heparin for acute submassive pulmonary embolism: assessment of patient-oriented cardiopulmonary outcomes at three months, J Am Coll Cardiol, 61, 10.1016/S0735-1097(13)62074-4 · doi:10.1016/s0735-1097(13)62074-4
  3. Stein, 2012, Intracerebral hemorrhage with thrombolytic therapy for acute pulmonary embolism, Am J Med, 125, 50, 10.1016/j.amjmed.2011.06.026 · doi:10.1016/j.amjmed.2011.06.026

Cited by

See all 605

Metadata

Authors
Marti, C., John, G., Konstantinides, S., Combescure, C., Sanchez, O., Lankeit, M., Meyer, G., & Perrier, A.
Venue
European Heart Journal
Published
2014-06-10
Volume
36
Issue
10
Pages
605-614
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2110112924
Cited by
605
References
40
FWCI
7.52
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1093/eurheartj/ehu218
The paper
Marti, C., John, G., Konstantinides, S., Combescure, C., Sanchez, O., Lankeit, M., Meyer, G., & Perrier, A. (2015). Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. European Heart Journal. https://doi.org/10.1093/eurheartj/ehu218

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.